CompletedPhase 4

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

Turkey (Türkiye)704 participantsStarted 2005-11

Plain-language summary

This study aims to investigate the effects of high flux dialyser use and ultra pure dialysate utilization on cardiovascular disease by evaluating cardiovascular morbidity and mortality, progression of carotid artery intima-media thickness and coronary artery calcifications, inflammatory state, lipid levels, nutritional status, and erythropoietin requirement in hemodialysis patient population. It is hypothesized that both interventions in this project may diminish cardiovascular disease in hemodialysis patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged between 18 and 80 years * On maintenance bicarbonate hemodialysis scheduled thrice weekly, at least 12 hours/week * Willingness to participate in the study with a written informed consent. Exclusion Criteria: * To be scheduled for living donor renal transplantation * To have serious life-limiting co-morbid situations; namely active malignancy, active infection, end-stage cardiac, pulmonary, or hepatic disease; pregnancy or lactating

What they're measuring

cardiovascular mortality, myocardial infarction, stroke, unstable angina pectoris requiring hospitalization, revascularization

Timeframe: three years

Trial details

NCT IDNCT00295191

SponsorEge University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-03

View on ClinicalTrials.gov More End-stage Renal Disease trials